➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Express Scripts
Merck
Mallinckrodt
McKesson

Last Updated: June 23, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Basmisanil


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Basmisanil?

Basmisanil is an investigational drug.

There have been 3 clinical trials for Basmisanil. The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2016.

The most common disease conditions in clinical trials are Schizophrenia, Cognition Disorders, and Stroke. The leading clinical trial sponsors are Hoffmann-La Roche and [disabled in preview].

Recent Clinical Trials for Basmisanil
TitleSponsorPhase
A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic StrokeHoffmann-La RochePhase 2
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With AntipsychoticsHoffmann-La RochePhase 2
A Brain Imaging Study to Assess GABAA Receptor Alpha5 Subunit Occupancy Following a Single Dose of RO5186582 in Japanese Healthy Volunteers.Hoffmann-La RochePhase 1

See all Basmisanil clinical trials

Clinical Trial Summary for Basmisanil

Top disease conditions for Basmisanil
Top clinical trial sponsors for Basmisanil

See all Basmisanil clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Merck
Moodys
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.